Home / Latest Reports / Statins Market

Statins Market By Drug Class, Therapeutic Treatment and End-User - Global Industry Analysis And Forecast To 2027

Published On : December 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC122209

Request Sample Inquiry Before Buying Request for Customization Check Discount

Statins Market By Drug Class (Simvastatin, Lovastatin, Astrovastatin, Pravastatin, Fluvastatin and Others) Therapeutic Treatment (Inflammatory disorders, Obesity, Cardiovascular disorders and Others); and End-User (Clinics and Hospitals) - Global Industry Analysis And Forecast To 2027

Industry Outlook

Statins is class of drug that is used for lowering the cholesterol level in blood; it does so by reducing the production of cholesterol by the liver. Statins acts as a blockage to the enzymes that are responsible for production of cholesterol. Cholesterol leads to development of atherosclerosis (condition in which cholesterol-containing plaques form in arteries); statins can stabilize this plaques and reduce their effect. The use of Statins is growing due to; increasing cases of high cholesterol caused due to changing lifestyle and food habits, increasing number of people affected from obesity, diabetes and cardiovascular disorders, rise in budget on healthcare sector in developing areas across the globe, technical development & improved healthcare amenities, etc. Therefore, the Statins Market is anticipated to expand and has tremendous scope during the forecast period. The global Statins Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Statins Market is based on segment, by Drug Class the market is segmented into Simvastatin, Lovastatin, Astrovastatin, Pravastatin, Fluvastatin and Others; by Therapeutic Treatment the market is segmented into Inflammatory disorders, Obesity, Cardiovascular disorders and Others; and by End-User the market is segmented into Clinics and Hospitals.

  • Statins Market, By Drug Class
  • Simvastatin
  • Lovastatin
  • Astrovastatin
  • Pravastatin
  • Fluvastatin
  • Others
  • Statins Market, By Therapeutic Treatment
  • Inflammatory disorders
  • Obesity
  • Cardiovascular disorders
  • Others
  • Statins Market, By End-User
  • Clinics
  • Hospitals

Regional Insights

On a global front, the Statins Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Statins Market, followed by European market.

Statins Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Aurobindo Pharma Ltd., Concord Biotech, Novartis International AG, AstraZeneca plc., Merck & Co. Inc., GlaxoSmithKline plc., Pfizer Inc. and Biocon. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Aurobindo Pharma Ltd.
  • Concord Biotech
  • Novartis International AG
  • AstraZeneca plc.
  • Merck & Co. Inc.
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Biocon

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Statins Market, By Drug Class, Estimates and Forecast, 2017-2027 ($Million)

o   Simvastatin

o   Lovastatin

o   Astrovastatin

o   Pravastatin

o   Fluvastatin

o   Others

o   Statins Market, By Therapeutic Treatment, Estimates and Forecast, 2017-2027 ($Million)

o   Inflammatory disorders

o   Obesity

o   Cardiovascular disorders

o   Others

o   Statins Market, By End-User, Estimates and Forecast, 2017-2027 ($Million)

o   Clinics

o   Hospitals

o   Statins Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Statins Market, By Country

o   U.S. Statins Market

o   Canada Statins Market

o   Mexico Statins Market

o   Europe

§  Europe Statins Market, By Country

o   Germany Statins Market

o   UK Statins Market

o   France Statins Market

o   Russia Statins Market

o   Italy Statins Market

o   Rest of Europe Statins Market

o   Asia-Pacific

§  Asia-Pacific Statins Market, By Country

o   China Statins Market

o   Japan Statins Market

o   South Korea  Statins Market

o   India Statins Market

o   Southeast Asia Statins Market

o   Rest of Asia-Pacific Statins Market

o   South America

§  South America Statins Market, By Country

o   Brazil Statins Market

o   Argentina Statins Market

o   Columbia Statins Market

o   Rest of South America Statins Market

o   Middle East and Africa

§  Middle East and Africa Statins Market, By Country

o   Saudi Arabia Statins Market

o   UAE Statins Market

o   Egypt Statins Market

o   Nigeria Statins Market

o   South Africa Statins Market

o   Rest of MEA Statins Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Statins Market, By Drug Class

5.1.     Introduction

5.2.     Global Statins Revenue and Market Share by Drug Class (2017-2027)

5.2.1.  Global Statins Revenue and Revenue Share by Drug Class (2017-2027)

5.3.     Simvastatin

5.3.1.  Global Simvastatin Revenue and Growth Rate (2017-2027)

5.4.     Lovastatin

5.4.1.  Global Lovastatin Revenue and Growth Rate (2017-2027)

5.5.     Astrovastatin

5.5.1.  Global Astrovastatin Revenue and Growth Rate (2017-2027)

5.6.     Pravastatin

5.6.1.  Global Pravastatin Revenue and Growth Rate (2017-2027)

5.7.     Fluvastatin

5.7.1.  Global Fluvastatin  Revenue and Growth Rate (2017-2027)

5.8.     Others

5.8.1.  Global Others Revenue and Growth Rate (2017-2027)

6.       Statins Market, By Therapeutic Treatment

6.1.     Introduction

6.2.     Global Statins Revenue and Market Share by Therapeutic Treatment (2017-2027)

6.2.1.  Global Statins Revenue and Revenue Share by Therapeutic Treatment (2017-2027)

6.3.     Inflammatory disorders

6.3.1.  Global Inflammatory disorders Revenue and Growth Rate (2017-2027)

6.4.     Obesity

6.4.1.  Global Obesity Revenue and Growth Rate (2017-2027)

6.5.     Cardiovascular disorders

6.5.1.  Global Cardiovascular disorders  Revenue and Growth Rate (2017-2027)

6.6.     Others

6.6.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Statins Market, By End-User

7.1.     Introduction

7.2.     Global Statins Revenue and Market Share by End-User  (2017-2027)

7.2.1.  Global Statins Revenue and Revenue Share by End-User  (2017-2027)

7.3.     Clinics

7.3.1.  Global Clinics  Revenue and Growth Rate (2017-2027)

7.4.     Hospitals

7.4.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

8.       Statins Market, By Region

8.1.     Introduction

8.2.     Global Statins Revenue and Market Share by Regions

8.2.1.  Global Statins Revenue by Regions (2017-2027)

8.3.     North America Statins by Countries

8.3.1.  North America Statins Revenue and Growth Rate (2017-2027)

8.3.2.  North America Statins Revenue (Million USD) by Countries (2017-2027)

8.3.3.  United States

8.3.3.1.  United States Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.4.  Canada

8.3.4.1.  Canada Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.5.  Mexico

8.3.5.1.  Mexico Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.     Europe Statins by Countries

8.4.1.  Europe Statins Revenue and Growth Rate (2017-2027)

8.4.2.  Europe Statins Revenue (Million USD) by Countries (2017-2027)

8.4.3.  Germany

8.4.3.1.  Germany Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.4.  France

8.4.4.1.  France Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.5.  UK

8.4.5.1.  UK Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.6.  Russia

8.4.6.1.  Russia Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.7.  Italy

8.4.7.1.  Italy Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.     Asia-Pacific Statins by Countries

8.5.1.  Asia-Pacific Statins Revenue and Growth Rate (2017-2027)

8.5.2.  Asia-Pacific Statins Revenue (Million USD) by Countries (2017-2027)

8.5.3.  China

8.5.3.1.  China Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.4.  Japan

8.5.4.1.  Japan Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.5.  Korea

8.5.5.1.  Korea Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.6.  India

8.5.6.1.  India Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.     South America Statins by Countries

8.6.1.  South America Statins Revenue and Growth Rate (2017-2027)

8.6.2.  South America Statins Revenue (Million USD) by Countries (2017-2027)

8.6.3.  Brazil

8.6.3.1.  Brazil Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.4.  Argentina

8.6.4.1.  Argentina Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.5.  Columbia

8.6.5.1.  Columbia Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.     Middle East and Africa Statins by Countries

8.7.1.  Middle East and Africa Statins Revenue and Growth Rate (2017-2027)

8.7.2.  Middle East and Africa Statins Revenue (Million USD) by Countries (2017-2027)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.5.  Egypt

8.7.5.1.  Egypt Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.7.  South Africa

8.7.7.1.  South Africa Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.8.  Turkey

8.7.8.1.  Turkey Statins Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Statins Revenue (Millions USD) and Growth Rate (2017-2027)

9.       Company Profiles

9.1.     Aurobindo Pharma Ltd.

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.   Revenue and Market Share

9.2.     Concord Biotech

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.   Revenue and Market Share

9.3.     Novartis International AG

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.   Revenue and Market Share

9.4.     AstraZeneca plc.

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.   Revenue and Market Share

9.5.     Merck & Co. Inc.

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.   Revenue and Market Share

9.6.     GlaxoSmithKline plc.

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.   Revenue and Market Share

9.7.     Pfizer Inc.

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.   Revenue and Market Share

9.8.     Biocon

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.   Revenue and Market Share

10.    Global Statins Market Competition, by Manufacturer

10.1. Global Statins Revenue and Market Share by Manufacturer (2017-2017)

10.2. Global Statins Price By Region (2017-2017)

10.3. Top 5 Statins Manufacturer Market Share

10.4. Market Competition Trend

11.    Statins Market Forecast (2017-2027)

11.1. Global Statins Revenue (Millions USD) and Growth Rate (2017-2027)

11.2. Statins Market Forecast by Regions (2017-2027)

11.2.1.      North America Statins Market Forecast (2017-2027)

11.2.1.1. United States Statins Market Forecast (2017-2027)

11.2.1.2. Canada Statins Market Forecast (2017-2027)

11.2.1.3. Mexico Statins Market Forecast (2017-2027)

11.2.2.      Europe Statins Market Forecast (2017-2027)

11.2.2.1. Germany Statins Market Forecast (2017-2027)

11.2.2.2. France Statins Market Forecast (2017-2027)

11.2.2.3. UK Statins Market Forecast (2017-2027)

11.2.2.4. Russia Statins Market Forecast (2017-2027)

11.2.2.5. Italy Statins Market Forecast (2017-2027)

11.2.2.6. Rest of Europe Statins Market Forecast (2017-2027)

11.2.3.      Asia-Pacific Statins Market Forecast (2017-2027)

11.2.3.1. China Statins Market Forecast (2017-2027)

11.2.3.2. Japan Statins Market Forecast (2017-2027)

11.2.3.3. Korea Statins Market Forecast (2017-2027)

11.2.3.4. India Statins Market Forecast (2017-2027)

11.2.3.5. Southeast Asia Statins Market Forecast (2017-2027)

11.2.3.6. Rest of Asia-Pacific Statins Market Forecast (2017-2027)

11.2.4.      South America Statins Market Forecast (2017-2027)

11.2.4.1. Brazil Statins Market Forecast (2017-2027)

11.2.4.2. Argentina Statins Market Forecast (2017-2027)

11.2.4.3. Columbia Statins Market Forecast (2017-2027)

11.2.4.4. Rest of South America Statins Market Forecast (2017-2027)

11.2.5.      Middle East and Africa Statins Market Forecast (2017-2027)

11.2.5.1. Saudi Arabia Statins Market Forecast (2017-2027)

11.2.5.2. United Arab Emirates Statins Market Forecast (2017-2027)

11.2.5.3. Egypt Statins Market Forecast (2017-2027)

11.2.5.4. Nigeria Statins Market Forecast (2017-2027)

11.2.5.5. South Africa Statins Market Forecast (2017-2027)

11.2.5.6. Turkey Statins Market Forecast (2017-2027)

11.2.5.7. Rest of Middle East and Africa Statins Market Forecast (2017-2027)

11.3. Statins Market Forecast by Drug Class (2017-2027)

11.3.1.      Statins Forecast by Drug Class (2017-2027)

11.3.2.      Statins Market Share Forecast by Drug Class (2017-2027)

11.4. Statins Market Forecast by Therapeutic Treatment (2017-2027)

11.4.1.      Statins Forecast by Therapeutic Treatment (2017-2027)

11.4.2.      Statins Market Share Forecast by Therapeutic Treatment (2017-2027)

11.5. Statins Market Forecast by End-User  (2017-2027)

11.5.1.      Statins Forecast by End-User  (2017-2027)

11.5.2.      Statins Market Share Forecast by End-User  (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Statins Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Statins Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Statins Revenue and Revenue Share by Drug Class (2017-2018)
Figure Global Simvastatin Revenue and Growth Rate (2017-2018)
Figure Global Lovastatin Revenue and Growth Rate (2017-2018)
Figure Global Astrovastatin Revenue and Growth Rate (2017-2018)
Figure Global Pravastatin Revenue and Growth Rate (2017-2018)
Figure Global Fluvastatin Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Statins Revenue and Revenue Share by Therapeutic Treatment (2017-2018)
Figure Global Inflammatory disorders Revenue and Growth Rate (2017-2018)
Figure Global Obesity Revenue and Growth Rate (2017-2018)
Figure Global Cardiovascular disorders Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Statins Revenue and Revenue Share by End-User (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Table Global Statins Revenue by Regions (2017-2018)
Figure North America Statins Growth Rate (2017-2018)
Figure North America Statins Revenue and Growth Rate (2017-2018)
Figure North America Statins by Countries (2017-2018)
Figure North America Statins Revenue (Million USD) by Countries (2017-2018)
Figure United States Statins Growth Rate (2017-2018)
Figure United States Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Statins Growth Rate (2017-2018)
Figure Canada Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Statins Growth Rate (2017-2018)
Figure Mexico Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Statins Growth Rate (2017-2018)
Figure Europe Statins Revenue and Growth Rate (2017-2018)
Figure Europe Statins by Countries (2017-2018)
Figure Europe Statins Revenue (Million USD) by Countries (2017-2018)
Figure Germany Statins Growth Rate (2017-2018)
Figure Germany Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Statins Growth Rate (2017-2018)
Figure France Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Statins Growth Rate (2017-2018)
Figure UK Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Statins Growth Rate (2017-2018)
Figure Russia Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Statins Growth Rate (2017-2018)
Figure Italy Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Statins Growth Rate (2017-2018)
Figure Rest of Europe Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Statins Growth Rate (2017-2018)
Figure Asia-Pacific Statins Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Statins by Countries (2017-2018)
Figure Asia-Pacific Statins Revenue (Million USD) by Countries (2017-2018)
Figure China Statins Growth Rate (2017-2018)
Figure China Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Statins Growth Rate (2017-2018)
Figure Japan Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Statins Growth Rate (2017-2018)
Figure Korea Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Statins Growth Rate (2017-2018)
Figure India Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Statins Growth Rate (2017-2018)
Figure Southeast Asia Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Statins Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Statins Growth Rate (2017-2018)
Figure South America Statins Revenue and Growth Rate (2017-2018)
Figure South America Statins by Countries (2017-2018)
Figure South America Statins Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Statins Growth Rate (2017-2018)
Figure Brazil Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Statins Growth Rate (2017-2018)
Figure Argentina Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Statins Growth Rate (2017-2018)
Figure Columbia Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Statins Growth Rate (2017-2018)
Figure Rest of South America Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Statins Growth Rate (2017-2018)
Figure Middle East and Africa Statins Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Statins by Countries (2017-2018)
Figure Middle East and Africa Statins Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Statins Growth Rate (2017-2018)
Figure Saudi Arabia Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Statins Growth Rate (2017-2018)
Figure United Arab Emirates Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Statins Growth Rate (2017-2018)
Figure Egypt Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Statins Growth Rate (2017-2018)
Figure Nigeria Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Statins Growth Rate (2017-2018)
Figure South Africa Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Statins Growth Rate (2017-2018)
Figure Turkey Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Statins Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Statins Revenue (Millions USD) and Growth Rate (2017-2018)
Table Aurobindo Pharma Ltd. Statins Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Concord Biotech Statins Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis International AG Statins Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AstraZeneca plc. Statins Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck & Co. Inc. Statins Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline plc. Statins Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Statins Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Biocon Statins Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Statins Market Share by Manufacturer
Figure Global Statins Revenue and Market Share by Manufacturer
Table Global Statins Price by Region (2017-2017)
Figure Top 5 Statins Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Statins Revenue (Millions USD) and Growth Rate (2018-2025)
Table Statins Market Forecast by Regions (2018-2025)
Figure North America Statins Market Forecast (2018-2025)
Figure United States Statins Market Forecast (2018-2025)
Figure Canada Statins Market Forecast (2018-2025)
Figure Mexico Statins Market Forecast (2018-2025)
Figure Europe Statins Market Forecast (2018-2025)
Figure Germany Statins Market Forecast (2018-2025)
Figure France Statins Market Forecast (2018-2025)
Figure UK Statins Market Forecast (2018-2025)
Figure Russia Statins Market Forecast (2018-2025)
Figure Italy Statins Market Forecast (2018-2025)
Figure Rest of Europe Statins Market Forecast (2018-2025)
Figure Asia-Pacific Statins Market Forecast (2018-2025)
Figure China Statins Market Forecast (2018-2025)
Figure Japan Statins Market Forecast (2018-2025)
Figure Korea Statins Market Forecast (2018-2025)
Figure India Statins Market Forecast (2018-2025)
Figure Southeast Asia Statins Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Statins Market Forecast (2018-2025)
Figure South America Statins Market Forecast (2018-2025)
Figure Brazil Statins Market Forecast (2018-2025)
Figure Argentina Statins Market Forecast (2018-2025)
Figure Columbia Statins Market Forecast (2018-2025)
Figure Rest of South America Statins Market Forecast (2018-2025)
Figure Middle East and Africa Statins Market Forecast (2018-2025)
Figure Saudi Arabia Statins Market Forecast (2018-2025)
Figure United Arab Emirates Statins Market Forecast (2018-2025)
Figure Egypt Statins Market Forecast (2018-2025)
Figure Nigeria Statins Market Forecast (2018-2025)
Figure South Africa Statins Market Forecast (2018-2025)
Figure Turkey Statins Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Statins Market Forecast (2018-2025)
Figure Global Statins Forecast by Drug Class (2018-2025)
Figure Global Statins Market Share Forecast by Drug Class (2018-2025)
Figure Global Statins Forecast by Drug Class (2018-2025)
Figure Global Statins Forecast by Therapeutic Treatment (2018-2025)
Figure Global Statins Market Share Forecast by Therapeutic Treatment (2018-2025)
Figure Global Statins Forecast by Therapeutic Treatment (2018-2025)
Figure Global Statins Forecast by End-User (2018-2025)
Figure Global Statins Market Share Forecast by End-User (2018-2025)
Figure Global Statins Forecast by End-User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*